Sitafloxacin hydrate

CAS: 163253-35-8
Molecular Formula: C19H18ClF2N3O3.H2O
Molecular Weight: 427.833
Product description:A broad-spectrum antibiotic quinolone class, by Japan's first three, pharmaceutical research and development success, because of the molecular structure contains a cis fluorine ring propylamine, and have good pharmacokinetic characteristics, and can reduce adverse reaction, the in vitro antibacterial activity than most other drugs. Oral tablet and fine grained agent has been listed in Japan for the first time in June 2008, for the treatment of severe refractory infectious diseases. Injection dosage form is by Japan's first pharmaceutical company in Japan for phase III clinical trials, used in the treatment of bacterial infections.